| NVDA 176.4772 -5.45% | SOXL 55.185 20.05% | JDZG 0.2852 35.68% | SOC 1.0287 -46.70% | SHFS 0.0258 -1.90% | HRTX 0.3784 29.15% | INLF 0.2935 27.44% | GPUS 0.2033 42.27% | NVD 5.7399 11.02% | EDSA 3.0303 41.60% | SOXS 56.73 -20.04% | NTCL 0.2513 10.46% | INTC 58.485 3.92% | TQQQ 57.105 9.29% | KORU 7.585 9.77% | SPCX 142.4943 6.13% | SPDN 8.655 -2.04% | XHLD 0.807 38.66% | IREN 21.9186 1.29% | ZURA 1.09 -73.35% | PARA 0.0822 -28.21% | NWGL 2.73 7.91% | BDMD 0.0883 0.34% | SQQQ 43.226 -9.38% | DVLT 0.06199 -8.57% | PLUG 1.49 2.76% | NVDL 21.105 -10.99% | GRAB 3.414 0.12% | WULF 12.3 8.18% | IBRX 7.035 -18.53% | AAL 14.075 6.79% | TTD 15.005 16.05% | TSLL 9.735 10.63% | RWM 14.265 -2.76% | TGE 0.3742 2.94% | NOK 8.215 7.25% | BITO 9.975 -1.04% | AMD 499.04 11.13% | RCT 0.0335 -20.99% | RBNE 0.1281 -2.36% | CRWV 49.515 6.71% | AMZN 268.62 3.59% | DBGI 0.1871 -33.82% | ONDS 6.03 13.03% | CIFR 6.8734 5.02% | QQQ 676.7076 3.14% | MUU 15.51 12.55% | OPEN 1.3532 -3.34% | SOXX 145.7472 6.75% | OMH 51.31 597.15%

Eton Q3 Earnings Call Highlights Growth and Pipeline Expansion

ETON raises its 2026 revenue outlook as Q3 sales surge 158%, fueled by HEMANGEOL growth, improving profitability and rare disease pipeline progress.

TC Trade Conquest Newsroom November 6, 2026 ·1 min read

Eton Q3 Earnings Call Highlights Growth and Pipeline Expansion

ETON raises its 2026 revenue outlook as Q3 sales surge 158%, fueled by HEMANGEOL growth, improving profitability and rare disease pipeline progress.

See the latest quote, chart and news for ETON.

Read the full story at zacks.com ↗

Want trade ideas like this in real time? Subscribe to Trade Conquest.

More news